Clinical Trial Update: Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating adjunctive aripiprazole in clozapine-treated patients with refractory schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)
• Clozapine (Clozapine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED